Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 6.87%203.01 | 189.95 | 173.93 | 160.76 | 143.82 |
| Cost Of Revenue | 9.90%84.35 | 76.75 | 72.77 | 67.35 | 59.25 |
| Gross Profit | 4.82%118.66 | 113.20 | 101.16 | 93.41 | 84.58 |
1.18%90.52 | 89.46 | 87.86 | 72.14 | 61.28 | |
| Selling, General, and Administrative | 6.06%61.33 | 57.83 | 62.99 | 51.44 | 46.02 |
| Research and Development | 7.75%29.18 | 31.63 | 24.88 | 20.70 | 15.26 |
| Operating Income/Loss | 18.56%28.14 | 23.74 | 13.30 | 21.27 | 23.30 |
| Nonoperating Income/Loss | 6.72%-4.04 | -4.33 | -4.81 | 0.36 | -0.27 |
| Income/Loss From Continuing Operations Before Tax | 24.20%24.10 | 19.41 | 8.49 | 21.63 | 23.03 |
| Income Tax Expense/Benefit, Deferred | 55.04%5.89 | 3.80 | 1.07 | - | - |
| Income Tax Expense/Benefit | 48.80%7.03 | 4.72 | 1.17 | -83.75 | -1.29 |
16.29%17.07 | 14.68 | 7.32 | 105.38 | 24.32 | |
| Attributable To Parent | 16.29%17.07 | 14.68 | 7.32 | 105.38 | 24.32 |
| Basic Average Shares | 0.32%34.69 | 34.58 | 34.38 | 0.08 | 34.11 |
| Diluted Average Shares | 0.30%40.83 | 40.71 | 36.19 | 0.13 | 40.75 |
| Basic Earnings Per Share | 16.67%0.49 | 0.42 | 0.21 | 3.10 | 0.71 |
| Diluted Earnings Per Share | 12.20%0.46 | 0.41 | 0.20 | 2.59 | 0.66 |